Long-term effects, potential drug interactions, and effects in specific populations including pregnant women, children, and those with certain medical conditions have not been studied
0.05 mL delivers the same dose at a higher concentration
The best evidence available is that BPC-157 results in improved outcomes in muscle, tendon, ligament, and bone injury models in animals. There are probably trials ongoing, but if we are being honest about the totality of evidence available to us right now , it is irresponsible to claim either way that BPC-157 does or does not increase performance
Treatment is typically lifelong for patients with pernicious anaemia or irreversible malabsorption conditions
That is why lifelong supplementation is standard for bariatric patients, a point Dr